Maximum quantity allowed is 999
CAS RN: 105816-04-4 | Product Number: N0912
Nateglinide

Purity: >98.0%(T)(HPLC)
- N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
500MG |
₹5,500.00
|
3 | 23 |
|
1G |
₹6,800.00
|
1 | 18 |
|
5G |
₹16,200.00
|
3 | 5 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | N0912 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__2__7NO__3 = 317.43 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container ![]() |
500MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 105816-04-4 |
Reaxys Registry Number | 6486870 |
PubChem Substance ID | 160871031 |
Merck Index (14) | 6428 |
MDL Number | MFCD00875706 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -36.5 to -40.0 deg(C=1, 0.1mol/L NaOH) |
Specific Rotation | -38° (C=1,0.1mol/L NaHO sol.) |
Solubility in water | Insoluble |
Degree of solubility in water | 0.0066 g/l |
RTECS# | SQ7318950 |
References
- Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexane-carbonyl)-D-phenylalanine (A-4166)
- The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects
- Pancreatic β-cell KATP channel activity and membrane-binding studies with nateglinide: a comparison with sulfonylureas and repaglinide
- Nateglinide (a review)
- Nateglinide quantification in rabbit plasma by HPLC: Optimization and application to pharmacokinetic study
- Development and validation of a stereoselective HPLC method for the determination of the in vitro transport of nateglinide enantiomers in rat intestine
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.